Universidad Complutense de Madrid
The American Chemical Society’s premier outreach program, ACS on Campus, is proud to partner with Universidad Complutense de Madrid for an event on September 25! Join us for an exciting day of professional development featuring publishing discussions, career tips, and the latest from ACS. Don’t miss out on the chance to make lasting connections over networking breaks.
You’ll hear from Chris Holland, Associate Editor, ACS Biomaterials Science & Engineering; Dr. Félix Calderón, Associate Editor, ACS Infectious Diseases; and Prof. Juan Bisquert, Senior Editor, Journal of Physical Chemistry Letters. and many more!
This event is open to all students and researchers studying the sciences – not just chemistry! Registration is highly recommended.
Welcome from the Dead and Vice-Dean
Opening Remarks & ACS Resources to Grow Your Future
Peer Review: Why, How to, and What Not to Do
Preparing Abstracts with Style and Substance
Write it, Speak it: Effective Communications
Félix Calderón, Ph.D.
Associate Editor, ACS Infectious Diseases
Head of the Tres Cantos Open Lab
Félix Calderón started his career at GSK in 2007 as medicinal chemist working in the Diseases of the Developing World unit at the Tres Cantos R&D site. Since then, he has hold different leading roles working across the organization at different R&D sites. In 2012 he was appointed manager of the Malaria and in 2018 Head of the Tres Cantos Openlab Foundation. Prior to GSK, his background includes a B.Sc. from the Autonoma University of Madrid and training in synthetic chemistry at the University of Turin (Italy), the Spanish National Council for Scientific Research (CSIC, Ph.D. awarded in 2006), and computational chemistry at the University of California Los Angeles (UCLA). He is associate editor of the American Chemical Society’s Infectious Diseases journal and member of the Fine Chemical Group of the London based Society for Chemistry and Industry (SCI). In 2018 he was appointed Head of the Tres Cantos Open Lab.
Chris Holland, Ph.D.
Associate Editor, ACS Biomaterials Science & Engineering
EPSRC Early Career Fellowship, The University of Sheffield in the Materials Science and Engineering Department
Chris is based in The University of Sheffield in the Materials Science and Engineering Department where he leads the Natural Materials Group (www.naturalmaterialsgroup.com). He currently holds an EPSRC Early Career Fellowship and was previously at Oxford Zoology where he undertook his degrees and JRF. Outside the lab he is an Associate Editor for ACS Biomaterials Science and Engineering and Chair of the IoM3 Natural Materials Association. His research uses tools developed for the physical sciences to better understand how processing effects performance in natural materials. Using silk as a model system and studying it is spun he has been able to gain unique insights into this material’s biodiversity, structure and evolution. Additionally, this work has made important links between natural and industrial fibre processing which has led to several patents and a fundamentally new way of designing, testing and fabricating bio-inspired materials which is now being realised as Co-ordinator of the H2020 FET Open project FLIPT (www.h2020flipt.eu).
Rosario Rodríguez Pardo, Ph.D.
R&D Coordinator, Cepsa Research Centre
Born in Ferrol (A Coruña), she got a degree in Chemistry from the University of Cádiz (Spain) in 1986. From 1986 to 1989, she had a grant from the Andalucía government to develop her bachelor thesis in the Analytical Chemistry Department at the Science University of Cádiz. She joined Cepsa in 1990 as technologist in the Lubricants Laboratory where she applied her experience in the development and improvement of analytical methods. Since 2012 she is manager of the Exploration and Production research department. She coordinates a research team that develops projects to improve oil recovery in the oil fields operated by Cepsa. Her team has developed Enhanced Oil Recovery (EOR) technologies adapted to different reservoir conditions. Their advances have been published in international conferences or patented.
Juan Bisquert, Ph.D.
Senior Editor, Journal of Physical Chemistry Letters
Director, Institute of Advanced Materials (INAM), Universitat Jaume I
Juan Bisquert is a professor of applied physics at Universitat Jaume I de Castelló. He is the director of the Institute of Advanced Materials, that develops research activity on materials, nanostructures and devices for production and efficient use of clean energies. He published 350 papers in research journals, and authored a series of books including Nanostructured Energy Devices and Physics of Solar Cells: Perovskites, Organics, and Photovoltaics Fundamentals (CRC Press). He has 27000 citations and an h-index of He is a Senior Editor of the Journal of Physical Chemistry Letters and member of the editorial board of Energy and Environmental Science. He has been on the distinguished list of 3000 Highly Cited Researchers from 2014 to 2017.
Monica Azulay, MA
Regional Sales Manager, EMEA, American Chemical Society, Publications Division
Monica joined the ACSI sales team based in Oxford in July 2014. Alongside her Regional Sales Manager reponsibilities in the EMEA region, Monica represents the ACS internationally, fostering the relationship between the ACS and their end-users, authors, customers and stakeholders. She is strongly committed to bringing the ACS closer to the scientific community outside the USA and she fully engages at every opportunity in outreach events such as ACS on Campus.
Project Leader – Medicinal Chemistry, ORYZON (Labs)
I obtained my degree in M. Sc from the Universidad of Barcelona, Barcelona, Spain in 1999 and afterwards I was working 1 year in a research group of Universidad of Barcelona in collaboration with the pharmaceutical company Grupo Vita. I joined Almirall Prodesfarma S.A (currently named as ALMIRALL S.A) in 2000 as part of the Combinatorial Chemistry research group holding different roles (drug design, set-up of a semipreparative HPLC, development of new solid phase synthesis technologies). From 2002, I became part the Medicinal Chemistry research group, where I was mainly involved in the design and synthesis of new drugs in several research programs of ALMIRALL. In 2009 I joined ORYZON GENOMICS S.A as Project Leader in Medicinal Chemistry, designing new drugs for epigenetic targets and managing several national and international collaborations